| Pharmaceutical active ingredients: |
| Guaifenesin |
| Available forms, composition and doses of Miorelax: |
| N / A |
| Miorelax medical category: |
| Human:Cough and cold preparationsExpectorants |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R05CA03 - Guaifenesin |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Mioran | Chlorzoxazone | Unidentified Pharmaceutical Company |
| Mioratrina | Carisoprodol | Unidentified Pharmaceutical Company |
| Miorel | Baclofen | Kleva |
| Miorel | Thiocolchicoside | Sankyo; Fornet Laboratoires |
| Mio-Rel | Orphenadrine | Unidentified Pharmaceutical Company |
| Mioril | Carisoprodol | Unidentified Pharmaceutical Company |
| Miorilas | Methocarbamol | Unidentified Pharmaceutical Company |
| Miorilax | Chlormezanone | Unidentified Pharmaceutical Company |
| Mioriodol | Carisoprodol | Unidentified Pharmaceutical Company |
| Miorrelax | Caffeine; Metamizole; Orphenadrine Citrate | Ducto Industria Farmaceutica Laboratorio |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Miolisodol | Carisoprodol | Unidentified Pharmaceutical Company |
| Mionitrat | Nitroglycerin | Unidentified Pharmaceutical Company |
| Mioran | Chlorzoxazone | Unidentified Pharmaceutical Company |
| Mioratrina | Carisoprodol | Unidentified Pharmaceutical Company |
| Mio-Rel | Orphenadrine | Unidentified Pharmaceutical Company |
| Mioril | Carisoprodol | Unidentified Pharmaceutical Company |
| Miorilas | Methocarbamol | Unidentified Pharmaceutical Company |
| Miorilax | Chlormezanone | Unidentified Pharmaceutical Company |
| Mioriodol | Carisoprodol | Unidentified Pharmaceutical Company |
| Mio-Sed | Chlormezanone | Unidentified Pharmaceutical Company |